Skip to main content
Equibles
CLOV logo

CLOV · Clover Health Investments, Corp. /De · Metrics

Track CLOV — free

Use CLOV with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.30 +0.01 (+0.30%)
Russell 2000 member Rebalance outlook locked
Market Cap
$2.28B
Shares
531.16M

CLOV metrics

66 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.29
Market cap
$2.28B

Price action

20 metrics
Price change (1W)
+0.6%
Price change (30D)
-6.9%
Price change (3M)
+11.1%
Price change (6M)
+112.8%
Price change (YTD)
+81.1%
Price change (1Y)
+58.2%
Trailing year
Price change (5Y)
-51.9%
52-week high
$5.41
52-week low
$1.70
Change from 52-week high
-21.3%
Change from 52-week low
+150.3%
Annualized volatility
66.9%
Annualized volatility (3M)
64.7%
Beta
1.3
RSI (14D)
47.5
Price vs SMA 50
-5.7%
Price vs SMA 200
+35.5%
Avg volume (3M)
5.86M
Relative volume
0.4
Average dollar volume
$27.48M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
531.16M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.9×
reciprocal yield 109.6%
P / book
6.0
reciprocal yield 16.6%
FCF yield
3.3%
TTM · current market cap
Buyback yield
0.0%
P / FCF
30.5
reciprocal yield 3.3%
P / operating cash flow
29.3
reciprocal yield 3.4%
Earnings yield
-0.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.3×
reciprocal yield 372.3%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 372.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
-0.7%
Trailing 12 months
Net margin
-0.7%
Gross profit (TTM)
$334.89M
Operating profit (TTM)
−$18.36M
Net income (TTM)
−$18.36M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
3.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+55.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.48B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+7.2%
Year over year · more shares
Revenue CAGR (3Y)
+20.6%
Revenue CAGR (5Y)
+23.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-4.9%
Return on assets
-2.5%
Debt / equity
—
Current ratio
1.5
EBITDA (TTM)
−$20.13M
Free cash flow (TTM)
$74.21M
Quick ratio
1.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$198.84M
Total assets
$720.33M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$77.03M
Capital expenditures (TTM)
$2.83M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$72.38M
R&D / revenue
—
Stock compensation / revenue
2.9%

Ownership (13F)

3 metrics
13F filers
228
13F filer change QoQ
+18
Institutional ownership
30.0%

Short interest

3 metrics
Short interest
4.9%
Latest settlement · 5.0 days to cover
Days to cover
5.0d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.15M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1801170 CUSIP 18914F103 13F (30d) 139 filings 139 filers Visit website Investor relations